The American College of Radiology (ACR), AdMeTech Foundation and European Society of Urogenital Radiology (ESUR) have formed a joint effort to expedite development of standards for the Magnetic Resonance Prostate Imaging Reporting and Data System (MR PI-RADS) modeled after a successful effort in breast cancer care.
The goal is to expedite the transfer of high-quality MRI from laboratories to patients to reduce unnecessary biopsies and treatment. Over-diagnosis and over-treatment associated with prostate-specific antigen testing has been highlighted by the U.S. Preventive Services Task Force, American Cancer Society and other groups.
MR PI-RADS is expected to be completed and ready for distribution in early 2013.
“MR PI-RADS will build on the ACR’s experience with the Breast Imaging Reporting and Data System (BI-RADS) that has led to improvements in breast cancer screening and treatment worldwide,” Jeffrey Weinreb, MD, ACR representative and co-chair of the MR PI-RADS Steering Committee, said in a statement.
MR PI-RADS will be based on prostate MRI guidelines developed by ESUR and the work by the Boston-based nonprofit AdMeTech Foundation's International Prostate MRI working group.
“Prostate cancer—the most common major cancer in the U.S. and the second most lethal malignancy in men—represents a major public health problem,” said Faina Shtern, MD, AdMeTech Foundation’s representative and a member of the ACR’S Steering Committee. “Advanced imaging technologies and their BI-RADS standardization enabled minimally-invasive, precisely-targeted diagnosis and treatment of breast cancer for women. Similarly, MR PI-RADS will transform prostate cancer care for men.”